Gynuity Health Projects
@gynuity.bsky.social
Reproductive & maternal health │ Non-profit with over 20 years' experience generating & promoting evidence to guide policy & inspire innovative practice
Reposted by Gynuity Health Projects
3. Many people prefer to skip the test
A 2020 study by @gynuity.bsky.social found nearly half of the 678 participants would choose same-day pills without a pregnancy test—and 70% of those who didn’t want to be pregnant said the same. Many said that skipping the test would reduce stress and stigma.🧵
A 2020 study by @gynuity.bsky.social found nearly half of the 678 participants would choose same-day pills without a pregnancy test—and 70% of those who didn’t want to be pregnant said the same. Many said that skipping the test would reduce stress and stigma.🧵
October 15, 2025 at 6:16 PM
3. Many people prefer to skip the test
A 2020 study by @gynuity.bsky.social found nearly half of the 678 participants would choose same-day pills without a pregnancy test—and 70% of those who didn’t want to be pregnant said the same. Many said that skipping the test would reduce stress and stigma.🧵
A 2020 study by @gynuity.bsky.social found nearly half of the 678 participants would choose same-day pills without a pregnancy test—and 70% of those who didn’t want to be pregnant said the same. Many said that skipping the test would reduce stress and stigma.🧵
This evaluation builds upon a study by @gynuity.bsky.social with @ppnorthcentral.bsky.social @pprockymountains.bsky.social, which suggests that providing medication abortion based only on a self-administered, programmed questionnaire is likely to be effective and safe gynuity.org/resources/ev...
Evaluation of a “Smart” Screening Tool for Asynchronous Assessment of Medication Abortion Eligibility: A Pilot Study - Gynuity Health Projects
gynuity.org
September 8, 2025 at 11:04 AM
This evaluation builds upon a study by @gynuity.bsky.social with @ppnorthcentral.bsky.social @pprockymountains.bsky.social, which suggests that providing medication abortion based only on a self-administered, programmed questionnaire is likely to be effective and safe gynuity.org/resources/ev...
Reposted by Gynuity Health Projects
Through this letter organized by CRHLP and ANSIRH, hundreds of researchers remind the FDA that it’s actions must be based on the sound, rigorous, and transparent science that conclusively proves the safety and effectiveness of mifepristone generally and via telehealth.
August 27, 2025 at 3:41 PM
Through this letter organized by CRHLP and ANSIRH, hundreds of researchers remind the FDA that it’s actions must be based on the sound, rigorous, and transparent science that conclusively proves the safety and effectiveness of mifepristone generally and via telehealth.
Este FAQ (preguntas frecuentes) también está disponible en español gynuity.org/assets/resou...
gynuity.org
June 5, 2025 at 9:22 AM
Este FAQ (preguntas frecuentes) también está disponible en español gynuity.org/assets/resou...